Cargando…
Droplet digital polymerase chain reaction offers an improvisation over conventional immunohistochemistry and fluorescent in situ hybridization for ascertaining Her2 status of breast cancer
BACKGROUND: Droplet digital polymerase chain reaction (DDPCR) is a recent modality for detecting Her2 expression which is quantitative, cheaper, easier to standardize, and free from interobserver variation. PURPOSE: The purpose of this study is to incorporate DDPCR in the current diagnostic paradigm...
Autores principales: | Suryavanshi, Moushumi, Jaipuria, Jiten, Mehta, Anurag, Kumar, Dushyant, Panigrahi, Manoj Kumar, Verma, Haristuti, Saifi, Mumtaz, Sharma, Sanjeev, Tandon, Simran, Doval, Dinesh Chandra, Das, Bhudev C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852626/ https://www.ncbi.nlm.nih.gov/pubmed/31807475 http://dx.doi.org/10.4103/sajc.sajc_344_18 |
Ejemplares similares
-
The detection of primary and secondary EGFR mutations using droplet digital PCR in patients with nonsmall cell lung cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2018) -
ROS1 rearrangement and response to crizotinib in Stage IV non-small cell lung cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2017) -
Predictive biomarkers in nonsmall cell carcinoma and their clinico-pathological association
por: Mehta, Anurag, et al.
Publicado: (2019) -
Diagnostic ability of real-time quantitative polymerase chain reaction versus immunohistochemistry for Ki-67 assessment in breast cancer: An Indian perspective
por: Mehta, Anurag, et al.
Publicado: (2019) -
Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India
por: Mehta, Anurag, et al.
Publicado: (2018)